Delivery Order SPE2DB24D1205-SPE2DB25FCSWT
Award Date
1/8/25
Potential Completion Date
1/9/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,205.11 firm fixed-price delivery order contract covers the supply of XCOPRI 150 MG TABLET 30S, a pharmaceutical product, with a performance period through January 6, 2025.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,080.02 firm fixed-price delivery order is for the supply of XCOPRI 100 MG TABLET 30S, a pharmaceutical product. The contract has a period of performance through December 18, 2024 and was awarded on December 17, 2024.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,082.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of XCOPRI 200 MG TABLET 30S, a pharmaceutical product. The award has an ultimate completion date of June 29, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of XCOPRI 150 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,173.90 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 22, 2024, with a completion date of October 23, 2024. This order is a part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $1,166.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XCOPRI 100 MG TABLET 30S, a pharmaceutical product, with an ultimate completion date of November 6, 2024.
The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of XCOPRI 200 MG Tablets. The contract, which is a Delivery Order valued at $5,147.10, has a period of performance through September 18, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, was awarded this firm fixed-price contract without any set-aside designation. The contract is part of a larger...
This federal contract award, valued at $1,139.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of XCOPRI 50 MG TABLET 30S, a pharmaceutical product. The award is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is November 14, 2024. There is no set-aside designation mentioned in the information provided. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division. The $1,673.45 firm fixed-price Delivery Order (SPE2DB22FT57N) is for the supply of XCOPRI 100 MG TABLET 30S, a pharmaceutical product, with an ultimate completion date of August 11, 2022. This award is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (SPE2DB20D2104) with the DLA, which...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract worth $1,263.65 to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of 4566736030 XCOPRI 200 MG TABLET 30S, a prescription medication. This Delivery Order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,623.99 firm fixed price delivery order is for the supply of the pharmaceutical product XCOPRI 100 MG TABLET 30S.
Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, to provide a comprehensive range of...